ARCHIVES

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

This article is from The Cancer Letter archive.

Vol. 25 No. 46 | December 3, 1999

Download PDF Visit The Full Archive

Related Articles

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

September 30, 2011

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

Finasteride Does Not Affect Quality of Life, Says Study

September 28, 2012

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977